Association between proprotein convertase subtilisin/kexin type 9 (PCSK9) and subclinical cerebrovascular disease in the community.
Ayako KunimuraYuichiro YanoTakashi HisamatsuSayuki ToriiKeiko KondoAya KadotaAkira FujiyoshiTomonori OkamuraYoshiyuki WatanabeAkihiko ShiinoKazuhiko NozakiHirotsugu UeshimaKatsuyuki Miuranull nullPublished in: European journal of neurology (2023)
Higher circulating PCSK9 levels were independently associated with a ICAS prevalence but not with a CSVD prevalence. The quantification of circulating PCSK9 levels may help to identify individuals at high risk for cerebrovascular disease in the general population.